We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Taser Shocks May Cause Cardiac Arrest

By HospiMedica International staff writers
Posted on 24 May 2012
A shock to the chest from a taser or other electronic control devices (ECDs) may cause sudden cardiac arrest and death, according to a new study.

A researcher at the Indiana University School of Medicine (Indianapolis, USA) examined eight cases of Taser X26 ECD-induced loss of consciousness; all but one individual died. More...
In each instance, when available, police, medical and emergency response records, ECD dataport interrogation, automated external defibrillator (AED) information, electrocardiogram (ECG) strips, depositions, and autopsy results were analyzed. All eight men had previously been clinically healthy, all received shocks in the anterior chest near or over the heart, and all lost consciousness during or immediately after the shock.

The results showed that ECD stimulation could cause cardiac electrical capture and provoke cardiac arrest due to ventricular tachycardia/ventricular fibrillation (VT/VF). After prolonged VT/VF without resuscitation, asystole developed. The researchers hypothesized that one of the potential mechanisms of ventricular fibrillation from a taser shock could come from a sudden loss of blood pressure from an initial shock-induced increase in heart rate, which is exacerbated by repeated shocks, potentially causing ischemia and subsequently provoking ventricular fibrillation. The study was published early online on April 30, 2012, in Circulation.

“Avoid chest shocks if possible, monitor the person following a shock, suspect the possibility of an arrhythmia in those who lose consciousness, and be prepared to resuscitate, including the use of an automated external defibrillator,” concluded and advised study author Douglas Zipes, MD.

The Taser X26, manufactured by Taser International (Scottsdale, AZ, USA), is classified as a nonlethal weapon; as such it is not considered a firearm, and therefore not regulated by the US Bureau of Alcohol, Tobacco, Firearms, and Explosives. It is, however, capable of delivering an initial shock of 50,000 volts, followed by shorter 1,200-volt shocks that the user can stop, repeat, or sustain longer. The safety of stun guns has been questioned, particularly by Amnesty International, which reported more than 500 deaths in the US following shocks from stun guns since 2001.

Related Links:

Indiana University School of Medicine
Taser International



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.